Home/Filings/4/0001349929-17-000017
4//SEC Filing

CANCER GENETICS, INC 4

Accession 0001349929-17-000017

CIK 0001349929operating

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:52 PM ET

Size

5.5 KB

Accession

0001349929-17-000017

Insider Transaction Report

Form 4
Period: 2017-02-22
ROBERTS JOHN A
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2017-02-22+30,00030,000 total
    Exercise: $2.50Exp: 2027-02-22Common Stock, par value $0.0001 per share (30,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option shall vest in 48 equal monthly installments commencing on the date of grant until fully vested, provided that the reporting person remains a service provider to Cancer Genetics, Inc. through each applicable vesting period.

Issuer

CANCER GENETICS, INC

CIK 0001349929

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001349929

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:52 PM ET
Size
5.5 KB